Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

india-pharmacy

  1. Home>
  2. News>
  3. india-pharmacy>
  4. Page 16

WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You

  • Post published:June 2, 2026
  • Post category:Knowledge

🔬 WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You India supplies approximately 20% of the world's generic medicines by volume, making it the largest…

Continue Reading WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You

CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

  • Post published:June 1, 2026
  • Post category:News

The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…

Continue Reading CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

  • Post published:May 29, 2026
  • Post category:Knowledge

India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug…

Continue Reading How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know

  • Post published:May 28, 2026
  • Post category:News

The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…

Continue Reading US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know
  • Go to the previous page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Go to the next page

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
    September 1, 2026/
    0 Comments
  • India Pushes for Pharma Market Access in Argentina and Brazil
    August 31, 2026/
    0 Comments
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
    August 30, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
  • CBN and PHARMEXCIL Sign MoU on Controlled Substances Exports
  • Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve